GLYE yields 1000000.00% · JNJ yields 2.13%● Live data
📍 GLYE pulled ahead of the other in Year 1
Combined, GLYE + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GLYE + JNJ for your $10,000?
GlyEco, Inc., a specialty chemical company, develops, manufactures, and distributes performance fluids for the automotive, commercial, and industrial markets in North America. It develops, manufactures, and markets additive packages for the antifreeze/coolant, gas patch coolant, and heat transfer industries; and METALGUARD additive package product line comprising one-step inhibitor systems to make various types of antifreeze concentrates and 50/50 coolants for automobiles, heavy-duty diesel engines, stationary engines in gas patch, and other applications, as well as METALGUARD heat transfer fluids that include propylene and ethylene glycol based light and heavy-duty fluids for various operating temperatures. It also operates a glycol re-distillation plant in West Virginia, which processes waste glycol into virgin quality recycled glycol for sale to industrial customers worldwide. GlyEco, Inc. was founded in 1996 and is based in Institute, West Virginia.
Full GLYE Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.